Thursday’s big stock stories: What’s likely to move the market in the next trading session

Investing

A trader works on the floor of the New York Stock Exchange.
NYSE

Stocks @ Night is a daily newsletter delivered after hours, giving you a first look at tomorrow and last look at today. Sign up for free to receive it directly in your inbox.

Office demand and office stocks

  • CNBC TV’s Diana Olick will report on the state of office demand in the U.S. on Thursday, with a special focus on New York City.
  • SL Green is up roughly 12% in a month, and it’s gained 20% in three months. The stock has dropped 11% since the July high.
  • Vornado is up 16.6% in a month, and it’s added 24% in three months. The stock is 7% from the December high.
  • CBRE is up 22% in a month, but the stock has dropped 7% from the July 31st high.
  • BXP is up 12% in a month, and it’s higher by 11% in three months. The stock is 8.7% from the December high.

Eli Lilly

  • The pharma giant will report quarterly numbers on Thursday morning.
  • Eli Lilly is up 32.5% so far in 2024.
  • The stock is 20% from the July high.
  • Eli Lilly is flat since over the past three months.

Retail earnings

  • Under Armour reports before the bell.
  • Capri Holdings reports after the bell. Their brands include Versace, Jimmy Choo and Michael Kors.
  • Class C shares of Under Armour are down 4.4% over the past three months. The stock is 30% from the December high.
  • Capri is down 13.7% in three months, and it’s 41.5% from the high hit almost a year ago.
Stock Chart IconStock chart icon

Capri Holdings, 3-month performance

Other retailers

  • Etsy hit a four-year low on Wednesday. The stock is 40% from the December high. The stock is down 18% in a week.
  • Ulta Beauty hit a 37-month low Wednesday. This stock is 44% from the March high, and it’s down 12% in a week.
  • Dollar Tree hit a 34-month low on Wednesday. The stock is down about 37% in a year, and it’s off by 22% in three months.
Stock Chart IconStock chart icon

Dollar Tree, one-year performance

Articles You May Like

Wall Street bankers on course for up to 35% bonus bump
Bitcoin to be ‘political imperative,’ owning none ‘a liability’ — NYDIG
Caligan picks up a stake in Verona Pharma, seeing an opportunity to generate more value
Top Wall Street analysts like these dividend-paying stocks
Megacap tech stocks make some room — here is where investors are branching out